On Monday the share price of the small-cap company rose 3.5 percent and hit its 52-week high of Rs 1,618 per share from the previous close of Rs 1,562.25 after the company received an order worth Rs 14.3 crore.
According to a filing by Newgen Software Technologies Ltd, the company has received an order for the Procurement of a Loan Originating System (LOS) Platform with Accelerators (Retail, MSME, Collections, and SRM) worth Rs 14.3 Crores over three years.
Looking at the financials of Newgen Software Technologies Ltd, net revenue increased by 30.6 percent year on year, from Rs 202 crore in Q2FY23 to Rs 264 crore in Q2FY24.
Furthermore, the company’s net profit increased by 63 percent year on year, from Rs 27 crore in Q2FY23 to Rs 44 crore in Q2FY24. The small-cap multibagger company has a market capitalization of Rs 11,010 Crores.
The share price has risen 140 percent in the last six months and 338 percent in the last year. For example, if an investor invested Rs 1 Lakh a year ago the current value would be around Rs 4.38 Lakhs.
Newgen Software Technologies Ltd has a return on equity of 20 percent, a return on capital employed of 24 percent, and a net profit margin of 18 percent. Also, the company has maintained a zero debt-to-equity ratio.
The promoters own 55 percent of the company, while foreign institutional investors own 16 percent, domestic institutional investors own 9 percent, and the general public owns 20 percent.
Newgen Software Technologies is a global software company that develops software products, including designing and delivering end-to-end software solutions that cover the entire spectrum of software services, from workflow automation to document management to imaging.
Written by Sriram KV
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
